The CALYM Carnot Institute and the Institut Roche, Partners to Accelerate Together Research against Lymphoma!
<p class="chapo"> At the end of December 2017, a framework contract was signed between <a href="/en/carnot-institute/calym" target="_blank">CALYM</a> and the<a href="http://www.roche.fr/innovation-recherche-medicale/institut-roche.html&q…; target="_blank"> Institut Roche</a> to define the terms of a joint call for projects for the development of preclinical and translational research partnerships in onco-hematology.</p> <p> The CALYM Carnot institute aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase. To transform its discoveries of basic research into clinical applications for the patient, the institute benefits from the financial support of the French government (National Research Agency) andrelies on public-private partnerships it develops with industry and other research and technological organizations.</p> <p> It is in this context that CALYM has come closer to the Institut Roche which missions are to lead and develop strategic projects of basic or translational research in partnership with the French research teams of excellence.</p> <p> <a class="lien" href="https://www.calym.org/The-CALYM-Carnot-Institute-and-the.html" target="_blank"><strong><em>More information</em></strong></a></p>
